<- Go Home
Biofrontera Inc.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Market Cap
$11.2M
Volume
219.0K
Cash and Equivalents
$6.4M
EBITDA
-$11.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$30.7M
Profit Margin
73.71%
52 Week High
$1.19
52 Week Low
$0.54
Dividend
N/A
Price / Book Value
1.07
Price / Earnings
-0.93
Price / Tangible Book Value
1.43
Enterprise Value
$10.9M
Enterprise Value / EBITDA
-0.98
Operating Income
-$11.3M
Return on Equity
141.30%
Return on Assets
-28.00
Cash and Short Term Investments
$6.4M
Debt
$6.2M
Equity
$10.5M
Revenue
$41.7M
Unlevered FCF
-$2.1M
Sector
Pharmaceuticals
Category
N/A